Delivery Order SPE2DB20D6037-SPE2DB22FC9ZP
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract, valued at $2,783.55, has an ultimate completion date of April 23, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including prescription drugs, over-the-counter medications, and medical consumables. The contract, valued at up to $1,412.68, supports the recurring medical supply needs of military health facilities worldwide. This award is part of a larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued up to $1,543.92, covers the delivery of various medications including branded and generic prescription drugs, over-the-counter products, biologics, and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of various pharmaceutical products. The contract, valued at $2,347.08, has a period of performance through September 6, 2022. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to supply a variety of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The delivery order, valued at $4,169.59, is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including medications and medical supplies. The delivery order, valued at $2,494.50, has a completion date of September 13, 2022. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which allows the DLA to issue...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued at up to $21,322.56, has an ultimate completion date of August 31, 2023. DMS Pharmaceutical Group is an established supplier of branded and generic prescription drugs,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of a variety of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract, valued at $7,104.00, has an ultimate completion date of August 28, 2024. This delivery order falls under a larger indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the medical needs of military health facilities worldwide. The contract, valued at up to $12,508.75, covers the delivery of various medications and medical consumables, including branded and generic prescription drugs, over-the-counter...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,443.50 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valid through April 2025, is for the provision of pharmaceutical products and medical supplies to the DLA's Medical Supply Chain. This contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) awarded to DMS Pharmaceutical Group, enabling the DLA to issue delivery orders for a comprehensive...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB22FC9ZPDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract, valued at $2,005.44, has an ultimate completion date of April 22, 2022. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 4/21/22 |